Share-based Payment Arrangement, Expense of TuHURA Biosciences, Inc./NV from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TuHURA Biosciences, Inc./NV quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
  • TuHURA Biosciences, Inc./NV Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $1,424,736, a 326% increase year-over-year.
  • TuHURA Biosciences, Inc./NV annual Share-based Payment Arrangement, Expense for 2024 was $1,958,663, a 309% increase from 2023.
  • TuHURA Biosciences, Inc./NV annual Share-based Payment Arrangement, Expense for 2023 was $478,890, a 79% decline from 2022.
  • TuHURA Biosciences, Inc./NV annual Share-based Payment Arrangement, Expense for 2022 was $2,248,000, a 57% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

TuHURA Biosciences, Inc./NV Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,424,736 +$1,090,132 +326% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q3 2024 $98,000 -$62,000 -39% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q1 2024 $334,604 +$44,604 +15% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $165,000 -$271,000 -62% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 $160,000 -$358,000 -69% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q1 2023 $1,209,000 $290,000 -$352,000 -55% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q3
Q4 2022 $1,561,000 $436,000 -$394,000 -47% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q2
Q3 2022 $1,955,000 $518,000 -$293,000 -36% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2024 Q1
Q2 2022 $2,248,000 $35,000 -$1,063,000 -103% 01 Apr 2022 30 Jun 2022 10-K 18 Sep 2023 2023 FY
Q1 2022 $3,311,000 $642,000 -$1,076,000 -63% 01 Jan 2022 31 Mar 2022 10-Q 13 May 2022 2022 Q3
Q4 2021 $4,387,000 $830,000 -$1,295,000 -61% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q2
Q3 2021 $5,682,000 $811,000 +$406,000 +100% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q1
Q2 2021 $5,276,000 $1,028,000 +$840,000 +447% 01 Apr 2021 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q1 2021 $4,436,000 $1,718,000 +$1,622,000 +1690% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q3
Q4 2020 $2,814,000 $2,125,000 +$1,965,000 +1228% 01 Oct 2020 31 Dec 2020 10-Q 11 Feb 2022 2022 Q2
Q3 2020 $849,000 $405,000 +$354,000 +694% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q1
Q2 2020 $495,000 $188,000 +$117,359 +166% 01 Apr 2020 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 $377,641 $96,000 -$3,735 -3.7% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q3
Q4 2019 $381,376 $160,000 +$37,249 +30% 01 Oct 2019 31 Dec 2019 10-Q 12 Feb 2021 2021 Q2
Q3 2019 $344,127 $51,000 -$81,902 -62% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2021 Q1
Q2 2019 $426,029 $70,641 +$5,389 +8.3% 01 Apr 2019 30 Jun 2019 10-K 18 Sep 2020 2020 FY
Q1 2019 $420,640 $99,735 -$37,561 -27% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q3
Q4 2018 $458,201 $122,751 -$105,756 -46% 01 Oct 2018 31 Dec 2018 10-Q 13 Feb 2020 2020 Q2
Q3 2018 $563,957 $132,902 +$68,032 +105% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2020 Q1
Q2 2018 $495,925 $65,252 +$47,075 +259% 01 Apr 2018 30 Jun 2018 10-K 09 Sep 2019 2019 FY
Q1 2018 $448,850 $137,296 -$12,658 -8.4% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q3
Q4 2017 $461,508 $228,507 +$303,709 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019 2019 Q2
Q3 2017 $157,799 $64,870 +$33,052 +104% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2019 Q1
Q2 2017 $124,747 $18,177 -$237,244 -93% 01 Apr 2017 30 Jun 2017 10-K 24 Sep 2018 2018 FY
Q1 2017 $361,991 $149,954 +$126,111 +529% 01 Jan 2017 31 Mar 2017 10-Q 12 May 2017 2017 Q3
Q4 2016 $235,880 $75,202 -$150,164 -200% 01 Oct 2016 31 Dec 2016 10-Q 10 Feb 2017 2017 Q2
Q3 2016 $386,044 $31,818 -$8,088 -20% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q2 2016 $394,132 $255,421 +$210,692 +471% 01 Apr 2016 30 Jun 2016 10-K 27 Sep 2017 2017 FY
Q1 2016 $183,440 $23,843 -$39,005 -62% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q3
Q4 2015 $222,445 $74,962 +$44,579 +147% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017 2017 Q2
Q3 2015 $177,866 $39,906 -$9,034 -18% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2017 Q1
Q2 2015 $186,900 $44,729 +$43,638 +4000% 01 Apr 2015 30 Jun 2015 10-K 13 Sep 2016 2016 FY
Q1 2015 $143,262 $62,848 -$242,226 -79% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q3
Q4 2014 $385,488 $30,383 -$310,020 -91% 01 Oct 2014 31 Dec 2014 10-Q 12 Feb 2016 2016 Q2
Q3 2014 $695,508 $48,940 -$190,936 -80% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2016 Q1
Q2 2014 $886,444 $1,091 -$317,494 -100% 01 Apr 2014 30 Jun 2014 10-K 16 Nov 2015 2015 FY
Q1 2014 $1,203,938 $305,074 +$100,729 +49% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q3
Q4 2013 $1,103,209 $340,403 +$274,925 +420% 01 Oct 2013 31 Dec 2013 10-Q 12 Feb 2015 2015 Q2
Q3 2013 $828,284 $239,876 +$192,789 +409% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2015 Q1
Q2 2013 $635,495 $318,585 +$246,975 +345% 01 Apr 2013 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 $388,520 $204,345 +$115,926 +131% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q4 2012 $272,594 $65,478 01 Oct 2012 31 Dec 2012 10-K 28 Aug 2014 2014 FY
Q3 2012 $47,087 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013 2013 Q3
Q2 2012 $71,610 01 Apr 2012 30 Jun 2012 10-Q 12 Aug 2013 2013 Q2
Q1 2012 $88,419 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1

TuHURA Biosciences, Inc./NV Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,958,663 +$1,479,773 +309% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $478,890 -$1,769,110 -79% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $2,248,000 -$3,028,000 -57% 01 Jul 2021 30 Jun 2022 10-K 18 Sep 2023 2023 FY
2021 $5,276,000 +$4,781,000 +966% 01 Jul 2020 30 Jun 2021 10-K 27 Sep 2022 2022 FY
2020 $495,000 +$68,971 +16% 01 Jul 2019 30 Jun 2020 10-K 28 Sep 2021 2021 FY
2019 $426,029 -$69,896 -14% 01 Jul 2018 30 Jun 2019 10-K 18 Sep 2020 2020 FY
2018 $495,925 +$371,178 +298% 01 Jul 2017 30 Jun 2018 10-K 09 Sep 2019 2019 FY
2017 $124,747 -$269,385 -68% 01 Jul 2016 30 Jun 2017 10-K 24 Sep 2018 2018 FY
2016 $394,132 +$207,232 +111% 01 Jul 2015 30 Jun 2016 10-K 27 Sep 2017 2017 FY
2015 $186,900 -$699,544 -79% 01 Jul 2014 30 Jun 2015 10-K 13 Sep 2016 2016 FY
2014 $886,444 -$216,765 -20% 01 Jul 2013 30 Jun 2014 10-K 16 Nov 2015 2015 FY
2013 $1,103,209 +$830,615 +305% 01 Jan 2013 31 Dec 2013 10-K 28 Aug 2014 2014 FY
2012 $272,594 01 Jan 2012 31 Dec 2012 10-K 28 Aug 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.